[ Price : $8.95]
FDA grants Epizyme accelerated approval for Tazverik (tazemetostat), an EZH2 inhibitor for certain adult patients with relapsed or...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance on Patient-Focused Drug Development: Collecting Comprehensive and Re...[ Price : $8.95]
FDA issues an immediately-in-effect guidance on statistical considerations for proposed changes to clinical trials that may affect...[ Price : $8.95]
The Council for Responsible Nutrition asks FDA to lay out a regulatory pathway for approval of hemp-derived cannabidiol in dietary...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension for Obtaining Information to Understand Challen...[ Price : $8.95]
The watchdog group Accountable.US asks attorney general William Barr to be transparent about any political interference in a price...[ Price : $8.95]
Federal Register notice: FDA requests nominations for members to serve on its Pharmacy Compounding Advisory Committee.[ Price : $8.95]
FDA updates Covid-19 molecular test templates to help developers get tests authorized for broad screening of asymptomatic individu...